Type I collagen cell-binding domain (P-15)

The Type I collagen cell-binding domain is a specific amino acid sequence within the alpha-1 chain of Type I collagen that facilitates direct interaction between the extracellular matrix and cell surface receptors, primarily integrins like alpha-2 beta-1 (Bhatnagar et al., 1999). This domain is critical for mediating cell adhesion, migration, and the differentiation of mesenchymal stem cells into osteoblasts, which are essential for bone formation and repair (PubMed: 10463397). In clinical practice, synthetic analogs of this domain, such as the P-15 peptide, are utilized as bioactive coatings on bone graft substitutes to enhance the recruitment and attachment of bone-forming cells (Cerapedics, 2024). These therapeutic applications are widely used in orthopedic and dental surgeries to treat non-union fractures, periodontal defects, and to facilitate spinal fusion (PubMed: 19162877). By mimicking the natural scaffold of bone, these targets promote faster and more reliable tissue regeneration compared to passive grafting materials.

Other names

P-15 peptideCollagen alpha-1(I) chain cell-binding domainGFOGER motifIntegrin-binding domain of Type I collagenSynthetic P-15 peptide

The domain mimics the natural cell-binding sequence of Type I collagen, specifically binding to alpha-2 beta-1 (α2β1) integrins on the surface of osteogenic cells (Bhatnagar et al., 1999; PubMed: 10463397). This binding triggers intracellular signaling cascades, such as the MAPK/ERK pathway, which promote cell attachment, proliferation, and the expression of osteogenic markers like alkaline phosphatase and osteocalcin, facilitating the recruitment of bone-forming cells to the graft site (Hennessy et al., 2009; PubMed: 19162877).